TNF-α inhibitor protects against myocardial ischemia/reperfusion injury via Notchl-mediated suppression of oxidative/nitrative stress

被引:70
|
作者
Pei, Haifeng [1 ]
Song, Xiaofeng [1 ]
Peng, Chengfei [2 ,3 ]
Tan, Yan [1 ]
Li, Ying [1 ]
Li, Xia [4 ,5 ]
Ma, Shuangtao [1 ]
Wang, Qiang [1 ]
Huang, Rong [1 ]
Yang, Dachun [1 ]
Li, De [1 ]
Gao, Erhe [6 ]
Yang, Yongjian [1 ]
机构
[1] Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu 610083, Peoples R China
[2] Gen Hosp Shenyang Mil Reg, Cardiovasc Res Inst, Shenyang 110016, Peoples R China
[3] Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang 110016, Peoples R China
[4] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China
[5] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China
[6] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA
关键词
Myocardial ischemia/reperfusion; Oxidative/nitrative stress; Notch1; TNF-alpha inhibitor; Free radicals; TUMOR-NECROSIS-FACTOR; T-CELL-ACTIVATION; HEART-FAILURE; ISCHEMIA-REPERFUSION; INFARCT SIZE; NITRIC-OXIDE; DISEASE; PEROXYNITRITE; PATHWAY; MICE;
D O I
10.1016/j.freeradbiomed.2015.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TNF-alpha inhibitor reportedly protects against myocardial ischemia/reperfusion (MYR) injury. It can also increase Notch1 expression in inflammatory bowel disease, revealing the regulation of Notchl signaling by TNF-alpha inhibitor. However, the interaction between TNF-alpha inhibitor and Notchl signaling in MI/R remains unclear. This study aimed to determine the involvement of TNF-alpha inhibitor with Notchl in MI/R and delineate the related mechanism. Notchl -specific small interfering RNA (20 mu g) or Jaggedl (a Notch ligand, 12 mu g) was delivered through intramyocardial injection. Forty-eight hours after injection, mice received 30 min of myocardial ischemia followed by 3 h (for cell apoptosis and oxidative/nitrative stress) or 24 h (for infarct size and cardiac function) of reperfusion. Ten minutes before reperfusion, mice randomly received an intraperitoneal injection of vehicle, etanercept, diphenyleneiodonium, 1400W, or EUK134. Finally, downregulation of Notchl significantly reversed the alleviation of MI/R injury induced by etanercept, as evidenced by enlarged myocardial infarct size, suppressed cardiac function, and increased myocardial apoptosis. Moreover, Notchl blockade increased the expression of inducible NO synthase (iNOS) and gp(91phox), enhanced NO and superoxide production, and accelerated their cytotoxic reaction product, peroxynitrite. Furthermore, NADPH inhibition with diphenyleneiodonium or iNOS suppression with 1400W mitigated the aggravation of MI/R injury induced by Notchl downregulation in mice treated with etanercept. Additionally, either Notch] activation with Jaggedl or peroxynitrite decomposition with EUK134 reduced nitrotyrosine content and attenuated MI/R injury. These data indicate that MI/R injury can be attenuated by TNF-alpha inhibitor, partly via Notchl signaling-mediated suppression of oxidative/nitrative stress. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 121
页数:8
相关论文
共 50 条
  • [31] Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis
    Li, Ting
    Tan, Ying
    Ouyang, Shao
    He, Jin
    Liu, Lingling
    GENE, 2022, 808
  • [32] Losartan protects against myocardial ischemia and reperfusion injury via vascular integrity preservation
    Li, Yong
    Yao, Yufeng
    Li, Jia
    Chen, Qiuyun
    Zhang, Lu
    Wang, Qing K.
    FASEB JOURNAL, 2019, 33 (07): : 8555 - 8564
  • [33] Adiponectin protects against myocardial ischemia/reperfusion injury via production of nitric oxide
    Gonon, A. T.
    Widegren, U.
    Bulhak, A.
    Salehzadeh, F.
    Sjoquist, P. -O.
    Pernow, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 360 - 360
  • [34] Irisin Protects the Heart Against Myocardial Ischemia and Reperfusion Injury
    Wang, Hao
    Zhang, Shouyan
    Zhao, Yu T.
    Du, Jianfeng
    Zhao, Ting C.
    CIRCULATION, 2016, 134
  • [35] Tirofiban protects against myocardial ischemia and reperfusion injury in mice
    Qi Jianyong
    Zhang, Minzhou
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C5 - C5
  • [36] Shuxuening injection protects against myocardial ischemia-reperfusion injury through reducing oxidative stress, inflammation and thrombosis
    Wang, Ruiying
    Wang, Min
    Zhou, Jiahui
    Ye, Tianyuan
    Xie, Xueheng
    Ni, Dong
    Ye, Jingxue
    Han, Qiaoling
    Di, Caixia
    Guo, Liang
    Sun, Guibo
    Sun, Xiaobo
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (20)
  • [37] Monocarboxylate transporter 4 protects against myocardial ischemia/reperfusion injury by inducing oxidative phosphorylation/glycolysis interconversion and inhibiting oxidative stress
    Pan, Qiao
    Xie, Xiaobo
    Yuan, Qingxia
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2023, 50 (12) : 954 - 963
  • [38] Novel NLRP3 inflammasome inhibitor protects against myocardial ischemia/ reperfusion injury
    Rubeo, Chiara
    Comita, Stefano
    Pagliaro, Pasquale
    Bertinaria, Massimo
    Penna, Claudia
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 182 - 183
  • [39] Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway
    Mahmoud, Mona F.
    El Shazly, Shimaa M.
    Barakat, Waleed
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (05) : 465 - 471
  • [40] Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis
    Zhao, Li
    Shi, Hongtao
    Zhang, Fan
    Xue, Honghong
    Han, Qinghua
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 3411 - 3424